Abstract:The poor prognosis of patients with osteosarcoma remains a persistent problem, in particular for patients with unresectable tumors or metastasis. Therefore, combination of radiotherapy and chemotherapy has been considered for patients with metastasis or recurrence, patients unsuitable for surgery and patients refusing surgery. The present study aimed to investigate the effect of the combined treatment with cisplatin and radiation therapy on the biological characteristics of the osteosarcoma cell line MG-63 and the breast cancer 1 (BRCA1)-associated signaling pathways. Cell proliferation was determined using Cell Counting kit-8 assay, and cell apoptosis and cell cycle were assessed by flow cytometry. Cell migration was examined by Transwell assay. The mRNA and protein expression levels of candidate genes, including BRCA1 and p53, were determined by reverse transcription-quantitative PCR and western blotting, respectively. The results demonstrated that combined treatment with radiation and cisplatin significantly inhibited MG-63 cell proliferation compared with radiation or cisplatin treatment alone. Furthermore, radiation, cisplatin or the combined treatment with radiation and cisplatin increased the apoptosis rate of MG-63 cells, which resulted in G2 phase arrest, and significantly decreased the migratory capacity of MG-63 cells. In addition, the apoptosis rate of MG-63 cells following combined radiation and cisplatin treatment was higher compared with the cisplatin group, but lower compared with the radiation group. Furthermore, combined treatment with radiation and cisplatin decreased the mRNA and protein expression levels of BRCA1 and p53. Additionally, combined treatment with radiation and cisplatin had a more potent inhibitory effect on p53 expression than on BRCA1 expression. In addition, combination of radiation and cisplatin had a higher inhibitory effect on Bax protein level and a higher inductive effect on Bcl-2 protein level compared with treatments with radiation and cisplatin alone. The results demonstrated that combined treatment of radiation and cisplatin exhibited superior therapeutic effects on osteosarcoma MG-63 cells compared with radiation or cisplatin treatment alone, which may be mediated by the BRCA1-p53 signaling pathway.

Suppression of Osteosarcoma Cells Growth by 3-Aminobenzamide Combined with Cisplatin

Inhibitory Effects of PARP-1 Inhibitor on Growth of Human Osteosarcoma Cells.

The Poly(adp-Ribose) Polymerase-1 Inhibitor 3-Aminobenzamide Suppresses Cell Growth and Migration, Enhancing Suppressive Effects of Cisplatin in Osteosarcoma Cells.

Checkpoint Kinase Inhibitor AZD7762 Enhance Cisplatin-Induced Apoptosis in Osteosarcoma Cells.

Synergistic Apoptotic Effect of Crocin and Cisplatin on Osteosarcoma Cells Via Caspase Induced Apoptosis.

Enhancement of Osteosarcoma Cell Sensitivity to Cisplatin Using Paclitaxel in the Presence of Hyperthermia

Antisense C - Myc Sensitizes Osteosarcoma Cells to Cisplatin- Induced Apoptosis

ABT-737 Potentiates Cisplatin-Induced Apoptosis in Human Osteosarcoma Cells Via the Mitochondrial Apoptotic Pathway.

The Inhibitory Effects of Cisplatin-Radiation Combination Treatment on Malignant Osteosarcoma MG-63 Cells and BRCA1-p53 Pathways Are More Efficient Than Single Treatments.

Effect of Cinobufacini plus Cisplatin on the Proliferation and Apoptosis of Osteosarcoma U2OS Cells

Effects of poly (ADP-ribosyl) polymerase (PARP) inhibitor on cisplatin resistance & proliferation of the ovarian cancer C13 FNx01 cells

Effects of Poly (Adp-Ribosyl) Polymerase (parp) Inhibitor on Cisplatin Resistance & Proliferation of the Ovarian Cancer C13*Cells

Zoledronic Acid Enhanced the Antitumor Effect of Cisplatin on Orthotopic Osteosarcoma by ROS-PI3K/AKT Signaling and Attenuated Osteolysis.

In vitro cytotoxicity of cisplatin combined with carboplatin on osteosarcoma cell line OS-732

[Cytotoxic Effect of Cisplatin with Proteasome Inhibitor on Osteosarcoma Cells].

Radiosensitization of Osteosarcoma Cells Using the PARP Inhibitor Olaparib Combined with X-rays or Carbon Ions.

Berberine and Cisplatin Exhibit Synergistic Anticancer Effects on Osteosarcoma MG-63 Cells by Inhibiting the MAPK Pathway

Effects of vorinostat in combination with cisplatin on proliferation and apoptosis of human osteosarcoma cells

Proliferation Inhibition Effect of Docetaxel Combined with Cisplatin on Osteosarcoma Cells

The Synergistic Anticancer Effect of Cisplatin Combined with Oldenlandia Diffusa in Osteosarcoma MG-63 Cell Line in Vitro